Paint Therapeutics Email Formats
Biotechnology Research • • 1-10 Employees
Key Contact at Paint Therapeutics
Eric Springman
Co-Founder and Chief Operating Officer
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Founded | 2022 |
| Employees | 1-10 |
About Paint Therapeutics
Paint Therapeutics is reimagining drug delivery through the lungs. Our proprietary Peptide Drug Conjugate Platforms enable targeted pulmonary delivery with precise control over drug release and systemic exposure. We improve efficacy, reduce toxicity, and unlock new IP for therapies limited by oral administration, first-pass metabolism, or short half-lives. With PulmoPaint™ and SystemoPaint™, we have developed targeted delivery technologies that address longstanding limitations in efficacy, safety, and bioavailability.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Paint Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Paint Therapeutics has never raised funding before.
Paint Therapeutics Tech Stack
Discover the technologies and tools that power Paint Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Web servers
JavaScript libraries
Hosting
Form builders
Programming languages
Miscellaneous
Caching
Blogs
Analytics
JavaScript libraries
Databases
Page builders
United Kingdom
Belgium
South AfricaFrequently asked questions
4.8
40,000 users
